Anti-BACE1 and Antimicrobial Activities of Steroidal Compounds Isolated from Marine Urechis unicinctus
- PMID: 29538306
- PMCID: PMC5867638
- DOI: 10.3390/md16030094
Anti-BACE1 and Antimicrobial Activities of Steroidal Compounds Isolated from Marine Urechis unicinctus
Abstract
The human β-site amyloid cleaving enzyme (BACE1) has been considered as an effective drug target for treatment of Alzheimer's disease (AD). In this study, Urechis unicinctus (U. unicinctus), which is a Far East specialty food known as innkeeper worm, ethanol extract was studied by bioassay-directed fractionation and isolation to examine its potential β-site amyloid cleaving enzyme inhibitory and antimicrobial activity. The following compounds were characterized: hecogenin, cholest-4-en-3-one, cholesta-4,6-dien-3-ol, and hurgadacin. These compounds were identified by their mass spectrometry, ¹H, and 13C NMR spectral data, comparing those data with NIST/EPA/NIH Mass spectral database (NIST11) and published values. Hecogenin and cholest-4-en-3-one showed significant inhibitory activity against BACE1 with EC50 values of 116.3 and 390.6 µM, respectively. Cholesta-4,6-dien-3-ol and hurgadacin showed broad spectrum antimicrobial activity, particularly strongly against Escherichia coli (E. coli), Salmonella enterica (S. enterica), Pasteurella multocida (P. multocida), and Physalospora piricola (P. piricola), with minimal inhibitory concentration (MIC) ranging from 0.46 to 0.94 mg/mL. This is the first report regarding those four known compounds that were isolated from U. unicinctus and their anti-BACE1 and antimicrobial activity, highlighting the fact that known natural compounds may be a critical source of new medicine leads. These findings provide scientific evidence for potential application of those bioactive compounds for the development of AD drugs and antimicrobial agents.
Keywords: Alzheimer’s disease; BACE1; Urechis unicinctus; antimicrobial activity; bioassay-directed isolation; marine bioactive.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
Similar articles
-
Natural Compounds with Anti-BACE1 Activity as Promising Therapeutic Drugs for Treating Alzheimer's Disease.Planta Med. 2019 Nov;85(17):1316-1325. doi: 10.1055/a-1019-9819. Epub 2019 Oct 16. Planta Med. 2019. PMID: 31618777 Review.
-
Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.J Ethnopharmacol. 2016 Sep 15;191:152-160. doi: 10.1016/j.jep.2016.06.037. Epub 2016 Jun 15. J Ethnopharmacol. 2016. PMID: 27321278
-
BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.J Ethnopharmacol. 2016 Aug 22;190:219-30. doi: 10.1016/j.jep.2016.06.013. Epub 2016 Jun 5. J Ethnopharmacol. 2016. PMID: 27275774
-
BACE1 and cholinesterase inhibitory activities of Nelumbo nucifera embryos.Arch Pharm Res. 2015 Jun;38(6):1178-87. doi: 10.1007/s12272-014-0492-4. Epub 2014 Oct 11. Arch Pharm Res. 2015. PMID: 25300425
-
BACE1 Physiological Functions May Limit Its Use as Therapeutic Target for Alzheimer's Disease.Trends Neurosci. 2016 Mar;39(3):158-169. doi: 10.1016/j.tins.2016.01.003. Epub 2016 Jan 30. Trends Neurosci. 2016. PMID: 26833257 Review.
Cited by
-
Prospects of Marine Sterols against Pathobiology of Alzheimer's Disease: Pharmacological Insights and Technological Advances.Mar Drugs. 2021 Mar 20;19(3):167. doi: 10.3390/md19030167. Mar Drugs. 2021. PMID: 33804766 Free PMC article. Review.
-
4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters.Lipids Health Dis. 2019 Sep 2;18(1):168. doi: 10.1186/s12944-019-1103-7. Lipids Health Dis. 2019. PMID: 31477154 Free PMC article.
-
Chemical Profiling and Antioxidant, Anti-Inflammatory, Cytotoxic, Analgesic, and Antidiarrheal Activities from the Seeds of Commonly Available Red Grape (Vitis vinifera L.).Nutr Metab Insights. 2024 Sep 18;17:11786388241275100. doi: 10.1177/11786388241275100. eCollection 2024. Nutr Metab Insights. 2024. PMID: 39315363 Free PMC article.
-
Bioactive compounds from fermented Vernonia amygdalina leaf: Potent antibiotics against multidrug-resistant Escherichia coli and Salmonella typhi.In Silico Pharmacol. 2024 Nov 19;12(2):106. doi: 10.1007/s40203-024-00277-2. eCollection 2024. In Silico Pharmacol. 2024. PMID: 39569038
-
Non-rhizobial nodule endophytes improve nodulation, change root exudation pattern and promote the growth of lentil, for prospective application in fallow soil.Front Plant Sci. 2023 Apr 11;14:1152875. doi: 10.3389/fpls.2023.1152875. eCollection 2023. Front Plant Sci. 2023. PMID: 37113600 Free PMC article.
References
-
- Kalaria R., Maestre G.E., Arizaga R., Friedland R.P., Galasko D., Hall K., Luchsinger J.A., Ogunniyi A., Perry E.K., Potocnik F., et al. Alzheimer’s disease and vascular dementia in developing countries: Prevalence, management, and risk factors. Lancet Neurol. 2008;7:812–826. doi: 10.1016/S1474-4422(08)70169-8. - DOI - PMC - PubMed
-
- Prince M., Wimo A., Guerchet M., Ali G., Wu Y., Prina M. World Alzheimer Report 2015: The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends. Alzheimer’s Disease International; London, UK: 2015.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials